Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial.

Source:http://linkedlifedata.com/resource/pubmed/id/16572419

Download in:

View as

General Info

PMID
16572419